• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

游离胎儿 DNA 筛查罕见常染色体三体及部分染色体微缺失微重复综合征

Cell-free DNA screening for rare autosomal trisomies and segmental chromosome imbalances.

机构信息

Department of Obstetrics and Gynecology, Monash University, Clayton, Victoria, Australia.

Monash Women's, Monash Health, Clayton, Victoria, Australia.

出版信息

Prenat Diagn. 2022 Oct;42(11):1349-1357. doi: 10.1002/pd.6233. Epub 2022 Sep 22.

DOI:10.1002/pd.6233
PMID:36068932
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9826090/
Abstract

OBJECTIVE

To assess the outcomes of pregnancies at high-risk for rare autosomal trisomies (RATs) and segmental imbalances (SIs) on cell-free DNA (cfDNA) screening.

METHOD

A retrospective study of women who underwent cfDNA screening between September 2019 and July 2021 at three ultrasound services in Australia. Positive predictive values (PPVs) were calculated using fetal chromosomal analysis.

RESULTS

Among 23,857 women screened, there were 93 high-risk results for RATs (0.39%) and 82 for SIs (0.34%). The PPVs were 3.8% (3/78, 95% CI 0.8%-10.8%) for RATs and 19.1% (13/68, 95% CI 10.6%-30.5%) for SIs. If fetuses with structural anomalies were also counted as true-positive cases, the PPV for RATS increased to 8.5% (7/82, 95% CI 3.5%-16.8%). Among 85 discordant cases with birth outcomes available (65.4%), discordant positive RATs had a significantly higher proportion of infants born below the 10th and 3rd birthweight percentiles than expected (19.6% (p = 0.022) and 9.8% (p = 0.004), respectively), which was not observed in the SI group (2.9% < 10th (p = 0.168) and 0.0% <3rd (p = 0.305)).

CONCLUSION

The PPVs for SI and RAT results are low, except when a structural abnormality is also present. Discordant positive RATs are associated with growth restriction.

摘要

目的

评估细胞游离 DNA(cfDNA)筛查在罕见常染色体三体(RATs)和片段性不平衡(SIs)高危妊娠中的结局。

方法

对 2019 年 9 月至 2021 年 7 月在澳大利亚三个超声服务中心进行 cfDNA 筛查的女性进行回顾性研究。阳性预测值(PPV)通过胎儿染色体分析计算。

结果

在 23857 名筛查女性中,有 93 例 RATs(0.39%)和 82 例 SIs(0.34%)结果为高危。RATs 的 PPV 为 3.8%(78 例中的 3 例,95%CI 0.8%-10.8%),SIs 的 PPV 为 19.1%(68 例中的 13 例,95%CI 10.6%-30.5%)。如果将有结构异常的胎儿也视为真阳性病例,RATS 的 PPV 增加至 8.5%(82 例中的 7 例,95%CI 3.5%-16.8%)。在 85 例有出生结局的不一致病例中(65.4%),不一致的阳性 RATs 出生体重低于第 10 百分位和第 3 百分位的婴儿比例明显高于预期(19.6%(p=0.022)和 9.8%(p=0.004)),而 SIs 组则没有观察到这种情况(2.9%<10 百分位(p=0.168)和 0.0%<3 百分位(p=0.305))。

结论

SI 和 RAT 结果的 PPV 较低,除非同时存在结构异常。不一致的阳性 RATs 与生长受限有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f2/9826090/ae44244e2d59/PD-42-1349-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f2/9826090/110f69793260/PD-42-1349-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f2/9826090/ae44244e2d59/PD-42-1349-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f2/9826090/110f69793260/PD-42-1349-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f2/9826090/ae44244e2d59/PD-42-1349-g001.jpg

相似文献

1
Cell-free DNA screening for rare autosomal trisomies and segmental chromosome imbalances.游离胎儿 DNA 筛查罕见常染色体三体及部分染色体微缺失微重复综合征
Prenat Diagn. 2022 Oct;42(11):1349-1357. doi: 10.1002/pd.6233. Epub 2022 Sep 22.
2
Rare autosomal trisomies: comparison of detection through cell-free DNA analysis and direct chromosome preparation of chorionic villus samples.罕见的常染色体三体:通过游离 DNA 分析和直接绒毛膜取样染色体制备检测的比较。
Ultrasound Obstet Gynecol. 2019 Oct;54(4):458-467. doi: 10.1002/uog.20383. Epub 2019 Sep 3.
3
Clinical, Cytogenetic and Molecular Cytogenetic Outcomes of Cell-Free DNA Testing for Rare Chromosomal Anomalies.游离细胞 DNA 检测罕见染色体异常的临床、细胞遗传学和分子细胞遗传学结果。
Genes (Basel). 2022 Dec 16;13(12):2389. doi: 10.3390/genes13122389.
4
Usefulness and reliability of cell free fetal DNA screening for main trisomies in case of atypical profile on first trimester maternal serum screening.在早孕期母血清筛查非典型谱时,游离胎儿 DNA 筛查主要三体的有用性和可靠性。
J Transl Med. 2019 Nov 28;17(1):398. doi: 10.1186/s12967-019-02152-7.
5
Three years of clinical experience with a genome-wide cfDNA screening test for aneuploidies and copy-number variants.一项用于检测非整倍体和拷贝数变异的全基因组cfDNA筛查测试的三年临床经验。
Genet Med. 2021 Jul;23(7):1349-1355. doi: 10.1038/s41436-021-01135-8. Epub 2021 Mar 17.
6
Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test.英国国民医疗服务体系(NHS)中胎儿三体综合征常规筛查的临床实施:基于孕早期联合检测结果的游离DNA检测
Ultrasound Obstet Gynecol. 2016 Jan;47(1):45-52. doi: 10.1002/uog.15783. Epub 2015 Oct 26.
7
Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result.母体外周血游离 DNA 检测筛查三体的结果失败:后果分析。
Ultrasound Obstet Gynecol. 2016 Jun;47(6):698-704. doi: 10.1002/uog.15851. Epub 2016 Apr 25.
8
Incidence of chromosomal abnormalities in fetuses with first trimester ultrasound anomalies and a low-risk cell-free DNA test for common trisomies.早孕期超声异常且常见三体综合征游离 DNA 检测风险低的胎儿的染色体异常发生率。
Prenat Diagn. 2020 Oct;40(11):1474-1481. doi: 10.1002/pd.5799. Epub 2020 Aug 9.
9
Prospective first-trimester screening for trisomies by cell-free DNA testing of maternal blood in twin pregnancy.双胎妊娠孕妇母体外周血游离 DNA 检测行早孕期唐氏综合征筛查的前瞻性研究。
Ultrasound Obstet Gynecol. 2016 Jun;47(6):705-11. doi: 10.1002/uog.15913. Epub 2016 Apr 27.
10
Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.基于大型转诊基因诊断实验室数据的无细胞非侵入性产前筛查的阳性预测值估计
Am J Obstet Gynecol. 2017 Dec;217(6):691.e1-691.e6. doi: 10.1016/j.ajog.2017.10.005. Epub 2017 Oct 13.

引用本文的文献

1
Repeat cell-free DNA screening after initial false-positive results and term placental analysis for confined mosaicism: a prospective cohort study.初始假阳性结果后重复游离DNA筛查及针对局限性嵌合体的足月胎盘分析:一项前瞻性队列研究
Arch Gynecol Obstet. 2025 Aug 31. doi: 10.1007/s00404-025-08162-9.
2
Evaluation of the prenatal diagnostic value of non-invasive prenatal testing for the detection of rare fetal autosomal trisomies: a single center study of 83,842 cases.评估无创产前检测对罕见胎儿常染色体三体的产前诊断价值:一项83842例单中心研究
Sci Rep. 2025 Jul 19;15(1):26254. doi: 10.1038/s41598-025-09757-7.
3
Patient Preferences and Understanding of Genome-Wide Cell-Free DNA Screening for Foetal Chromosomal Imbalances: A Survey Study.

本文引用的文献

1
Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Follow-up results of the TRIDENT-2 study.全基因组无创性产前检测发现的附加结果的临床影响:TRIDENT-2 研究的随访结果。
Am J Hum Genet. 2022 Jun 2;109(6):1140-1152. doi: 10.1016/j.ajhg.2022.04.018.
2
Non-invasive prenatal screening tests may give false results, warns US regulator.美国监管机构警告称,非侵入性产前筛查测试可能会给出错误结果。
BMJ. 2022 Apr 22;377:o1031. doi: 10.1136/bmj.o1031.
3
Initial Clinical Experience with NIPT for Rare Autosomal Aneuploidies and Large Copy Number Variations.
患者对胎儿染色体失衡的全基因组游离DNA筛查的偏好与理解:一项调查研究。
Prenat Diagn. 2025 Jul;45(8):994-1003. doi: 10.1002/pd.6842. Epub 2025 Jun 19.
4
Prenatal Genome-Wide Cell-Free DNA Screening: Three Years of Clinical Experience in a Hospital Prenatal Diagnostic Unit in Spain.产前全基因组游离 DNA 筛查:西班牙一家医院产前诊断单位的三年临床经验。
Genes (Basel). 2024 Apr 28;15(5):568. doi: 10.3390/genes15050568.
5
[Value of non-invasive prenatal testing for rare autosomal trisomies in fetuses].[胎儿罕见常染色体三体非侵入性产前检测的价值]
Nan Fang Yi Ke Da Xue Xue Bao. 2023 Dec 20;43(12):2071-2077. doi: 10.12122/j.issn.1673-4254.2023.12.11.
无创产前检测用于罕见常染色体非整倍体和大片段拷贝数变异的初步临床经验
J Clin Med. 2022 Jan 13;11(2):372. doi: 10.3390/jcm11020372.
4
Influence of fibroids on cell-free DNA screening accuracy.子宫肌瘤对游离 DNA 筛查准确性的影响。
Ultrasound Obstet Gynecol. 2022 Jan;59(1):114-119. doi: 10.1002/uog.23763.
5
Clinical value for the detection of fetal chromosomal deletions/duplications by noninvasive prenatal testing in clinical practice.临床实践中应用无创产前检测技术检测胎儿染色体缺失/重复的临床价值。
Mol Genet Genomic Med. 2021 Jun;9(6):e1687. doi: 10.1002/mgg3.1687. Epub 2021 May 5.
6
Chromosomal mosaicism: Origins and clinical implications in preimplantation and prenatal diagnosis.染色体嵌合体:在胚胎植入前和产前诊断中的起源和临床意义。
Prenat Diagn. 2021 Apr;41(5):631-641. doi: 10.1002/pd.5931. Epub 2021 Mar 22.
7
Outcome of publicly funded nationwide first-tier noninvasive prenatal screening.全国性公共资助的一线无创产前筛查的结果。
Genet Med. 2021 Jun;23(6):1137-1142. doi: 10.1038/s41436-021-01101-4. Epub 2021 Feb 9.
8
Mechanisms of oocyte aneuploidy associated with advanced maternal age.高龄相关卵母细胞非整倍体的发生机制。
Mutat Res Rev Mutat Res. 2020 Jul-Sep;785:108320. doi: 10.1016/j.mrrev.2020.108320. Epub 2020 Jul 4.
9
Aneuploidy in first trimester chorionic villi and spontaneous abortions: Windows into the origin and fate of aneuploidy through embryonic and fetal development.早孕期绒毛组织中的非整倍体与自然流产:胚胎和胎儿发育过程中非整倍体来源和命运的窗口。
Prenat Diagn. 2021 Apr;41(5):519-524. doi: 10.1002/pd.5795. Epub 2020 Aug 4.
10
TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands.TRIDENT-2:荷兰全国范围内实施全基因组非侵入性产前筛查作为一级筛查检测。
Am J Hum Genet. 2019 Dec 5;105(6):1091-1101. doi: 10.1016/j.ajhg.2019.10.005. Epub 2019 Nov 7.